1021703

Inspection Details

Classification

No Action Indicated (NAI) (NAI)

End Date

July 20, 2017

Fiscal Year

2017

Product Type

Drugs

Project Area

Bioresearch Monitoring

Location

Minneapolis, MN (United States)

Additional Details